This NIH Exploratory/Developmental Grant is for supporting early and conceptual research projects, acknowledging the potential for considerable risk in pursuit of significant breakthroughs. This grant is for investigating the impact of opioids, either alone or in combination with other substances of misuse, on placenta function and neurodevelopment. Studies should specifically focus on the effects occurring during pregnancy and within the first year of life. The primary purpose is to advance understanding of how opioid exposure influences brain development and subsequent neurodevelopmental outcomes. Importantly, this funding opportunity strictly prohibits clinical trials, instead seeking exploratory or developmental research that could lead to novel techniques, methodologies, or applications.
Opportunity ID: 343290
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HD-23-031 |
| Funding Opportunity Title: | HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 29, 2022 |
| Last Updated Date: | Aug 29, 2022 |
| Original Closing Date for Applications: | Dec 07, 2022 |
| Current Closing Date for Applications: | Dec 07, 2022 |
| Archive Date: | Jan 12, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Small businesses Independent school districts Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments For profit organizations other than small businesses Private institutions of higher education County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities State governments Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. The purpose of this funding opportunity announcement (FOA) is to support developmental/exploratory studies of the impact of opioids, alone or in combination with other substances of misuse, on placenta function and neurodevelopment during pregnancy and in the first year of life. Clinical Trials are not permitted for this FOA; researchers proposing Basic Experimental Studies with Humans (BESH) should consider the companion FOA, RFA-HD-23-033, HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Basic Experimental Studies with Humans Required). |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-031.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00276587 | Nov 07, 2022 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278173 | Nov 08, 2022 | Dec 07, 2022 | View |
Package 1
Mandatory forms
343290 RR_SF424_5_0-5.0.pdf
343290 PHS398_CoverPageSupplement_5_0-5.0.pdf
343290 RR_OtherProjectInfo_1_4-1.4.pdf
343290 PerformanceSite_4_0-4.0.pdf
343290 RR_KeyPersonExpanded_4_0-4.0.pdf
343290 PHS398_ResearchPlan_4_0-4.0.pdf
343290 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343290 RR_Budget_3_0-3.0.pdf
343290 RR_SubawardBudget30_3_0-3.0.pdf
343290 PHS398_ModularBudget_1_2-1.2.pdf
343290 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
343290 RR_SF424_5_0-5.0.pdf
343290 PHS398_CoverPageSupplement_5_0-5.0.pdf
343290 RR_OtherProjectInfo_1_4-1.4.pdf
343290 PerformanceSite_4_0-4.0.pdf
343290 RR_KeyPersonExpanded_4_0-4.0.pdf
343290 PHS398_ResearchPlan_5_0-5.0.pdf
343290 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343290 RR_Budget_3_0-3.0.pdf
343290 RR_SubawardBudget30_3_0-3.0.pdf
343290 PHS398_ModularBudget_1_2-1.2.pdf
343290 PHS_AssignmentRequestForm_3_0-3.0.pdf